Institute Catalá Oncología -ko ikertzaileekin lankidetzan egindako argitalpenak (58)

2024

  1. Predictors of unsustained measurable residual disease negativity in transplant-eligible patients with multiple myeloma

    Blood, Vol. 143, Núm. 7, pp. 597-603

  2. “For and against” factors influencing participation in personalized breast cancer screening programs: a qualitative systematic review until March 2022

    Archives of Public Health, Vol. 82, Núm. 1

2023

  1. Development of a Guide to Multidimensional Needs Assessment in the Palliative Care Initial Encounter (MAP)

    Journal of Pain and Symptom Management, Vol. 66, Núm. 4, pp. 361-369.e6

  2. Epigenetic inactivation of the 5-methylcytosine RNA methyltransferase NSUN7 is associated with clinical outcome and therapeutic vulnerability in liver cancer

    Molecular Cancer, Vol. 22, Núm. 1

2022

  1. Mortality and biochemical recurrence after surgery, brachytherapy, or external radiotherapy for localized prostate cancer: a 10-year follow-up cohort study

    Scientific Reports, Vol. 12, Núm. 1

  2. Women's preference to apply shared decision-making in breast cancer screening: a discrete choice experiment

    BMJ Open, Vol. 12, Núm. 11

2021

  1. Chemotherapy or allogeneic transplantation in high-risk Philadelphia chromosome–negative adult lymphoblastic leukemia

    Blood, Vol. 137, Núm. 14, pp. 1879-1894

  2. Outcomes and prognostic factors of adults with refractory or relapsed T-cell acute lymphoblastic leukemia included in measurable residual disease-oriented trials

    Hematological Oncology, Vol. 39, Núm. 4, pp. 529-538

  3. Switching Ratio from Parenteral to Oral Methadone 1:1.2 Is Safer Compared with Ratio 1:2 in Patients with Controlled Cancer Pain: A Multicenter Randomized-Controlled Trial (RATIOMTD-010810)

    Journal of Palliative Medicine, Vol. 24, Núm. 3, pp. 382-390

  4. The potential role of imaging techniques in avoiding neck dissection during salvage surgery after head and neck carcinoma treated with bioradiotherapy

    Journal of Laryngology and Otology, Vol. 135, Núm. 11, pp. 970-975

2020

  1. Detection of somatic mutations in peritoneal lavages and plasma of endometrial cancer patients: A proof-of-concept study

    International Journal of Cancer, Vol. 147, Núm. 1, pp. 277-284

  2. Proactive and systematic multidimensional needs assessment in patients with advanced cancer approaching palliative care: A study protocol

    BMJ Open, Vol. 10, Núm. 2

  3. Radiation therapy for bone-only metastases in breast cancer patients: A GOCO survey of current clinical practice

    Reports of Practical Oncology and Radiotherapy, Vol. 25, Núm. 1, pp. 113-116

  4. T-Type Calcium Channels as Potential Therapeutic Targets in Vemurafenib-Resistant BRAFV600E Melanoma

    Journal of Investigative Dermatology, Vol. 140, Núm. 6, pp. 1253-1265

  5. Treatment of Frail Older Adults and Elderly Patients With Philadelphia Chromosome-negative Acute Lymphoblastic Leukemia: Results of a Prospective Trial With Minimal Chemotherapy

    Clinical Lymphoma, Myeloma and Leukemia, Vol. 20, Núm. 8, pp. e513-e522

2019

  1. Deficient Endoplasmic Reticulum-Mitochondrial Phosphatidylserine Transfer Causes Liver Disease

    Cell, Vol. 177, Núm. 4, pp. 881-895.e17

  2. Effect of information about the benefits and harms of mammography on women’s decision making: The InforMa randomised controlled trial

    PLoS ONE, Vol. 14, Núm. 3

  3. Phase II study of high-sensitivity genotyping of KRAS, NRAS, BRAF and PIK3CA to ultra-select metastatic colorectal cancer patients for panitumumab plus FOLFIRI: The ULTRA trial

    Annals of Oncology, Vol. 30, Núm. 5, pp. 796-803

  4. Pomalidomide-dexamethasone for treatment of soft-tissue plasmacytomas in patients with relapsed / refractory multiple myeloma

    European Journal of Haematology, Vol. 102, Núm. 5, pp. 389-394

  5. Tumor expression of cyclin-dependent kinase 5 (Cdk5) is a prognostic biomarker and predicts outcome of oxaliplatin-treated metastatic colorectal cancer patients

    Cancers, Vol. 11, Núm. 10